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The cytoplasmic domain of the 
 
Plasmodium falciparum
 
 
ligand EBA-175 is essential for invasion
but not protein trafﬁcking
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The Walter and Eliza Hall Institute of Medical Research, Melbourne 3050, Australia
 
he invasion of host cells by the malaria parasite
 
Plasmodium falciparum
 
 requires speciﬁc protein–pro-
tein interactions between parasite and host receptors
and an intracellular translocation machinery to power the
process. The transmembrane erythrocyte binding protein-
175 (EBA-175) and thrombospondin-related anonymous
protein (TRAP) play central roles in this process. EBA-175
binds to glycophorin A on human erythrocytes during the
invasion process, linking the parasite to the surface of the
host cell. In this report, we show that the cytoplasmic do-
T
 
main of EBA-175 encodes crucial information for its role in
merozoite invasion, and that trafﬁcking of this protein is in-
dependent of this domain. Further, we show that the cyto-
plasmic domain of TRAP, a protein that is not expressed in
merozoites but is essential for invasion of liver cells by the
sporozoite stage, can substitute for the cytoplasmic domain
of EBA-175. These results show that the parasite uses the
same components of its cellular machinery for invasion re-
gardless of the host cell type and invasive form.
 
Introduction
 
The intracellular parasite 
 
Plasmodium falciparum
 
 causes the
most severe form of malaria in humans and is responsible for
over two million deaths each year. Transmission of this proto-
zoan parasite occurs during feeding of the Anopheles mosquito
when sporozoite forms enter the human circulation and invade
liver cells. Merozoites develop within the liver cells and are
released into the blood where they invade erythrocytes. A
crucial step for the survival of the parasite is a fast and effi-
cient invasion process by both the sporozoite and merozoite
into their target cells, and this involves recognition, adhesion,
and active invasion of the respective host cell (Aikawa et al.,
1978; Barnwell and Galinski, 1998; Dubremetz et al.,
1998). After initial attachment of the parasite to the surface
of the target cell, the intruder establishes a tight junction
between its apical end and the host cell membrane. This
tight junction progressively moves toward the posterior of
the invading parasite as it enters the target cell. The process
is independent of the host cell, and appears to be driven by
intracellular translocation machinery involving transmem-
brane proteins and myosin motor modules (Dubremetz et
al., 1998; Pinder et al., 1998).
The invasion process into host cells involves proteins
located in specialized exocytic organelles (micronemes,
rhoptries, and granula) that define the electron-dense apical
pole of the invasive form of all Apicomplexa (Aikawa et al.,
1978; Dubremetz and Schwartzman, 1993; Carruthers and
Sibley, 1997). These proteins are targeted to their subcellular
location, and this is mediated by either specific amino acid
motifs or interaction with an escorter protein (Baldi et al.,
2000; Di Cristina et al., 2000; Hoppe et al., 2000; Reiss et
al., 2001; Cerede et al., 2002; Meissner et al., 2002; Ngo et
al., 2003). The secretion of proteins stored in these organelles
is essential for the invasion process. A group of micronemal
proteins involved in merozoite and sporozoite invasion are
each defined by an adhesive extracellular domain, a trans-
membrane region, and a cytoplasmic tail (Sultan et al.,
1997; Sibley et al., 1998; Adams et al., 2001; Michon et al.,
2002). These proteins are differentially expressed during the
parasite life cycle (Rogers et al., 1992b; Blair et al., 2002).
For example, in 
 
Plasmodia
 
, the thrombospondin-related
anonymous protein (TRAP)* is not expressed in the asexual
life cycle, but is an essential protein for sporozoite invasion
(Sultan et al., 1997). TRAP-deficient sporozoites are unable
to invade mosquito salivary gland cells or liver cells and do
not show any gliding motility. It has been proposed that the
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cytoplasmic domain of TRAP plays a role in connecting the
parasite actin–myosin machinery with the external substrate
(Kappe et al., 1999). It is interesting to note that besides
TRAP, just one other protein—the circumsporozoite pro-
tein—has been identified as playing a crucial role in the in-
vasion of hepatocytes by sporozoites (Menard et al., 1997).
In contrast, merozoites, the invasive form of the 
 
Plasmodia
 
asexual life cycle, use an array of adhesive transmembrane
proteins similar to TRAP (Sim et al., 1994; Reed et al.,
2000a; Duraisingh et al., 2003). For instance, members of
the erythrocyte binding-like superfamily can provide the
merozoite with high affinity binding ligands for a range of
receptors on the surface of the erythrocyte (Adams et al.,
2001). This multiplicity provides the genetic basis for ligand
diversity and different host cell receptor specificity. The rela-
tive importance and usage of the ligands for invasion of
merozoites is strain dependent (Hadley et al., 1987; Okoyeh
et al., 1999; Duraisingh et al., 2003). EBA-175 is the ligand
for glycophorin A, the dominant glycoprotein on the surface
of the erythrocyte (Sim et al., 1994). The interaction of this
ligand with its receptor defines one invasion pathway for
merozoites and is dependent on sialic acid moieties on the
receptor (Camus and Hadley, 1985). Disruption of this re-
ceptor–ligand interaction by either modifying the surface of
the erythrocytes or by gene disruption has shown that the
merozoite can use other invasion pathways (Dolan et al.,
1990; Reed et al., 2000a; Duraisingh et al., 2003). Loss of
function of EBA-175 in both sialic acid–dependent and –in-
dependent 
 
P. falciparum
 
 strains results in a decrease in inva-
sion of chymotrypsin-treated erythrocytes (Duraisingh et al.,
2003). This is due to the inability of these 
 
 
 
EBA-175 para-
sites to use the chymotrypsin-resistant receptor glycophorin
A. Additionally, in a sialic acid–dependent strain, disruption
of the EBA-175/glycophorin A pathway manifests itself in a
dramatic increase of invasion into neuraminidase-treated
erythrocytes. The receptor interaction of EBA-175 is medi-
ated by two adhesive modules (called F1/F2) located in the
extracellular domain (Adams et al., 1992); however, nothing
is known about the role of the cytoplasmic domain.
In this paper, we address the role of the cytoplasmic do-
main of EBA-175 in merozoite invasion via the glycophorin
A–dependent pathway of human erythrocytes. We show
that trafficking of EBA-175 is independent of its cytoplas-
mic domain. Further, we show that the cytoplasmic domain
of EBA-175 is essential for a functional EBA-175/glyco-
phorin A pathway and can be substituted by the cytoplasmic
domain of TRAP. This suggests that the invasion of sporo-
zoite and merozoite forms of 
 
Plasmodia
 
 into liver cells and
erythrocytes, respectively, use the same cellular machinery.
 
Results
 
Sequence comparison and mutation of the cytoplasmic 
domains of EBA-175
 
Micronemal proteins identified so far in 
 
P. falciparum
 
 and
other apicomplexa have an NH
 
2
 
-terminal signal peptide and
a single transmembrane domain with a short cytoplasmic tail
of 
 
 
 
50 amino acids at the COOH terminus (Di Cristina et
al., 2000; Adams et al., 2001). The cytoplasmic domains do
not display any overall homology, but have common fea-
tures in that they are rich in acidic amino acids (15–24%)
and have tyrosine-based motifs that may function in traffick-
ing of these proteins to the micronemes of the apical com-
plex (Fig. 1 A). The TRAP protein is localized within the
micronemes of the mosquito sporozoite stage (Rogers et al.,
1992a), whereas EBA-175 is expressed in the blood-stage
merozoites and is also localized in micronemes (Sim et al.,
1992). Both of these proteins function in invasion; however,
the target cell of the sporozoite is liver cells, whereas merozo-
ites invade erythrocytes.
To analyze the role of the EBA-175 cytoplasmic tail in
trafficking to the micronemes and in invasion of erythro-
cytes, we constructed transgenic 
 
P. falciparum
 
 that expressed
specific truncated, substituted, or mutated forms of this pro-
tein. This was done using the transfection vector pHH1 into
which 1.1 kb of the 3
 
 
 
 end of the 
 
EBA-175
 
 gene had been
cloned. This 
 
EBA
 
-
 
175
 
 fragment was amplified from cDNA
to remove the 3
 
 
 
 introns located in this region (Reed et al.,
2000a). The introns were removed to stabilize the transfec-
tion plasmid as previous constructs containing the introns
underwent frequent deletions.
Nine transfection plasmids based on pHH1 were con-
structed that would introduce specific alterations by allelic
replacement into the 3
 
 
 
 end of the 
 
EBA-175
 
 gene (Fig. 1
B; Triglia et al., 1998). As a control, we used pHH1–3
 
 
 
R
that would replace the 3
 
 
 
 end of the endogenous 
 
EBA-175
 
gene with cDNA coding for the same region. This would
express normal EBA-175 protein, and these parasites
would serve as a comparison for all transfectants. To deter-
mine if the cytoplasmic domain of TRAP could substitute
for the same region of EBA-175, we constructed pHH1–
175TRAP that would replace the 3
 
 
 
 end of 
 
EBA-175
 
 and
insert 114 bps of the 
 
TRAP
 
 gene. Additionally, we used the
plasmid pHH1-
 
 
 
230 that would allow deletion of the 3
 
 
 
cysteine-rich region, transmembrane, and cytoplasmic do-
mains. This transfection plasmid has been used previously
to produce a parasite line with a truncated EBA-175 that
disrupts the function of this protein (Reed et al., 2000a).
Importantly, transfection and integration of these plasmids
into the endogenous 
 
EBA-175
 
 gene by allelic replacement
would allow expression of the altered EBA-175 protein un-
der the control of the endogenous promoter (Triglia et al.,
1998).
The 10 pHH1-based plasmids were transfected into
W2mef parasites, and additionally, the plasmids pHH1–3
 
 
 
R
and pHH1-
 
 
 
tail were transfected into the 3D7 parasite line.
The transfected parasites were selected for integration via a
single crossover recombination event to derive: W2mef3
 
 
 
R,
W2mefY
 
1419
 
, W2mefY
 
1464
 
, W2mefYY, W2mefEDD,
W2mef
 
 
 
15, W2mefY
 
 
 
15, W2mefTRAP, W2mef
 
 
 
tail,
W2mef
 
 
 
230, 3D73
 
 
 
R, and 3D7
 
 
 
tail (Fig. 1, C and D). To
confirm that the plasmids had integrated, genomic DNA
from the parental line W2mef and 3D7 (as well as the 11
transfectants) was probed with an 
 
EBA-175
 
 fragment in
Southern hybridization experiments (Fig. 1 D). The struc-
ture of the integration events in the transfected parasite lines
was confirmed by additional restriction enzyme mapping ex-
periments (Fig. 1, C and D; unpublished data). The 
 
EBA-
175
 
 gene of each transfected parasite line was further ana-
lyzed by PCR and sequencing to confirm that the 3
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had been replaced and that the expected mutations, dele-
tion, or insertion were encoded within the gene.
 
Expression of mutant EBA-175 
in the transfected parasites
 
To confirm that the EBA-175 protein was expressed, we an-
alyzed parasites in schizont stages of parental lines W2mef
and 3D7, as well as the transfectants W2mef3
 
 
 
R,
W2mefY
 
1419
 
, W2mefY
 
1464
 
, W2mefYY, W2mefEDD,
W2mef
 
 
 
15, W2mefY
 
 
 
15, W2mefTRAP, W2mef
 
 
 
tail,
W2mef
 
 
 
230, 3D7
 
 
 
tail, and 3D73
 
 
 
R parasites by Western
blots with anti-EBA175, anti-EBA175-CT, anti-TRAP-CT,
and also anti-HSP70 antibodies as a loading control (Fig. 2
A). Anti-EBA175 antibodies detect the ectodomain of the
protein, and all of the parasite lines show expression of the
appropriately sized protein. Additionally, in 3D7 and in
3D7-derived transgenic parasites, a strong (
 
 
 
100 kD) cross-
reactive protein is detected. The W2mef
 
 
 
tail, 3D7
 
 
 
tail,
and W2mef
 
 
 
230 parasites express a protein smaller than
that observed for W2mef consistent with expression of the
truncated protein. Antibodies specific to the cytoplasmic
tail of EBA-175 detect the protein in W2mef, and all of
the transfectants except for W2mefTRAP, W2mef
 
 
 
tail,
W2mef
 
 
 
230, and 3D7
 
 
 
tail. This shows that these trans-
fected parasite lines express EBA-175 that lacks the cytoplas-
mic domain. The anti-EBA175-CT antibodies detect EBA-
175 in W2mefY
 
 
 
15 and W2mef
 
 
 
15 despite the deletion of
15 amino acids. This is not surprising, as both of these trun-
cated proteins retain 49 amino acids of the 64-amino acid
cytoplasmic tail to which the antibody was raised.
To test if W2mefTRAP expresses a chimeric EBA-175 pro-
tein containing the TRAP cytoplasmic domain, we used anti-
TRAP-CT antibodies in immunoblot experiments with the
same schizont preparations used above (Fig. 2 A). This anti-
body detects a protein in W2mefTRAP with the identical size
as that observed with anti-EBA175 antibodies; however, no
signal is obtained with any of the other parasite lines tested.
The level of expression of the different mutant and chi-
meric EBA-175 proteins in each of the transgenic parasites
was approximately the same as judged by multiple Western
blots using independent schizont preparations (Fig. 2; un-
published data). However, to further investigate the level of
transcription of 
 
EBA-175
 
 in W2mef
 
 
 
tail and 3D7
 
 
 
tail
parasites, W2mef3
 
 
 
R, 3D73’R, and parasite transcripts of
the EBA-175 gene were quantified by real-time RT-PCR
and compared with the relevant transfection controls
Figure 1. Sequence alignment of the cytoplasmic 
domain of microneme proteins and the EBA-175 
mutations used in this paper. Also shown is the 
EBA-175 allelic replacement and Southern blot 
analysis. (A) Comparison of the microneme proteins 
EBA-175, EBA-181 (JESEBL), EBA-140 (BAEBL), 
EBL1, AMA1, TRAP, EBA165 (PAEBL), and MAEBL. 
The COOH-terminal amino acids of the highly 
conserved transmembrane domain are in black 
italics, tyrosine motifs and tyrosine residues are 
indicated by red letters, acidic amino acids are 
highlighted in blue. (B) Sequences of the constructs 
used in this paper to modify the cytoplasmic domain 
of EBA-175. COOH-terminal amino acids of the 
transmembrane domain are in black italics, and 
amino acid substitutions are in red. In gray is the 
sequence of TRAP fused to EBA-175 backbone. 
(C) Schematic representation of the 3  replacement 
of the EBA-175 gene by single crossover recombi-
nation of pHH1 constructs in the EBA-175 locus. 
The positive selection cassette (hDHFR) of the 
pHH1 vector is represented by the black box. An 
 1.1-kb fragment of the COOH terminus with the 
introduced mutation (indicated by asterisks) was 
cloned in the pHH1 vector including the 3  cysteine 
rich region (purple), the transmembrane domain 
(black), and the mutated cytoplasmic domain 
(green). This fragment is flanked by the 3  UTR of 
the P. berghei dihydrofolate reductase gene (gray) 
in the pHH1 vector. Crosses refer to the regions 
where recombination events were expected. The 
intron/exon structure of the endogenous EBA-175 
gene is shown. The red boxes indicate the adhesive 
F1/F2 ectodomains of the endogenous EBA-175. 
The MfeI (M) restriction sites are marked and the position of the EBA-175 probe used for Southern analysis is indicated. (D) Southern blot 
analysis of genomic DNA (MfeI restricted) of W2mef and transgenic EBA-175 mutant parasites reveals that the plasmid has integrated into 
the EBA-175 gene. Variable numbers of plasmid copies have integrated into each transgenic parasite. The position of the probe used in the 
Southern hybridization leads to large fragments of 8.1 and 11 kb that differ in intensity depending on the number of plasmids integrated. 
The 2.4-kb band is indicative of the integration of the plasmid via single recombination into the 3  end of the EBA-175 gene. Importantly, 
the endogenous EBA-175 hybridizing band is 10 kb, and is different in the parasite lines where the 3  end of EBA-175 has been replaced. 
Sizes of the hybridizing bands are shown in kb.T
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W2mef3
 
 
 
R and 3D73
 
 
 
R (Fig. 2 B). No significant differ-
ences between W2mef3
 
 
 
R, W2mef
 
 
 
tail, 3D73
 
 
 
R, and
3D7
 
 
 
tail could be detected.
 
The cytoplasmic domain of EBA-175 is not required for 
localization of the protein to the micronemes
 
Previously, it has been shown that the cytoplasmic tail of
type 1 transmembrane proteins in Apicomplexa can contain
sorting signals that are essential for correct subcellular local-
ization (for review see Joiner and Roos, 2002). To determine
if the mutant EBA-175 proteins were correctly localized to
the micronemes, we used immunofluorescence to test colo-
calization with other microneme proteins including EBA-
181 (Gilberger et al., 2003) and EBA-140. Using the parasite
line W2mef
 
 
 
230, in which EBA-175 is expressed without
the 3
 
  
 
cysteine-rich region, transmembrane, and cytoplasmic
domain, we showed that this truncation leads to incorrect lo-
calization of truncated EBA-175 (Fig. 3). Although still de-
tectable in schizonts (Reed et al., 2000a), it does not colocal-
ize with the microneme marker EBA-181 and importantly is
not detectable in merozoites, as it appears to be released into
the supernatant on schizont rupture (Fig. 3). This was con-
firmed by colocalization with a second microneme marker
EBA-140 (unpublished data). Previously, it has been sug-
gested that the same truncated EBA-175 may be localized to
micronemes in schizont stages; however, no additional mi-
croneme markers were available at that time to confirm this
result, and immuno-localization in free merozoites was not
performed (Kaneko et al., 2000; Reed et al., 2000a).
In 
 
Toxoplasma gondii
 
, it has been shown that tyrosine-based
motifs are required for targeting of proteins to the micron-
emes and rhoptries (Di Cristina et al., 2000; Hoppe et al.,
2000). To test the role of the two tyrosine residues (Y-1419
and Y-1464) in microneme targeting of EBA-175, each
was  mutated in transfected parasite lines W2mefY
 
1419
 
 and
W2mefY
 
1464
 
. To rule out the requirement of only one of the
two Tyr residues, both were mutated in W2mefYY-trans-
fected parasites. Immunofluorescence of free merozoites from
Figure 2. Immunoblot analysis of trans-
genic parasites expressing different 
EBA-175 mutant proteins. Proteins from 
synchronized parasite cultures were 
separated by SDS-PAGE on a 6% gel 
under reducing conditions. Proteins were 
detected with anti-EBA175, anti-EBA175-
CT, anti-TRAP-CT, and anti-HSP70. 
Approximately equal signal was obtained 
with the anti-HSP70 antibodies, suggesting 
that each lane was loaded equally.
In 3D7-derived parasite pellets, an addi-
tional cross-reactive band of  100 kD is 
detected by anti-EBA-175 antibodies. 
(B) Bar graph of the relative expression 
ratio of EBA-175 in late schizont stages 
of selected parasites. This ratio was cal-
culated by dividing the average of three 
EBA175 assays with the average of the 
actin and histone 2B signals. The SD 
represents the sum of the EBA-175 and 
housekeeping SDs. The averages are 
calculated and the relative expression 
ratio is obtained by dividing the EBA-175 
value with a mean of each control.T
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W2mefY1419, W2mefY1464, and W2mefYY parasites with
anti-EBA-175 and anti-EBA-181 antibodies shows colocal-
ization, confirming that the mutant EBA-175 proteins are
located within the micronemes of these transfected parasites
(Fig. 3).
To test the role of charged amino acid residues in EBA-
175 trafficking, the amino acid residues E-1466, D-1467,
and D-1470 were mutated in W2mefEDD using the trans-
fection plasmid pHH1-EDD. Immunofluorescence of EBA-
175 in W2mefEDD showed colocalization with EBA-181 in
free merozoites, demonstrating that it was located within the
micronemes (Fig. 3). To further investigate the possible syn-
ergistic role for trafficking of the acidic acid cluster and the
tyrosines, we constructed the parasites W2mef 15 and
W2mefY 15. These parasites express a truncated EBA-175
without the COOH-terminal acidic acid cluster EDD and
without either one or both tyrosines. Immunofluorescence
experiments with these transgenic parasites showed the same
subcellular localization of mutated EBA-175 and EBA-181
in free merozoites, confirming that they are both present in
micronemes (Fig. 3).
Finally, to determine if the cytoplasmic tail is required
for trafficking of EBA-175 to the micronemes at all, we
constructed transfected parasites W2mef tail and 3D7 tail
that express truncated forms of the protein. Although these
parasites express EBA-175 without a cytoplasmic domain,
this truncated protein is still trafficked to the micronemes
(Fig. 3). Therefore, the cytoplasmic domain of EBA-175 is
not required for localization of the protein to micronemes
in P. falciparum.
Figure 3. Immunolocalization of EBA-175 
mutant proteins in transgenic parasites. The 
names on the left refer to the W2mef parasite 
lines expressing mutant EBA-175 proteins. The 
structure of EBA-175 and mutant proteins are 
schematically shown. Free merozoites were 
incubated with anti-EBA175 and anti-EBA181, 
followed by FITC-labeled anti–mouse and 
rhodamine-labeled anti–rabbit antibodies. To 
precisely visualize the localization of mutant 
EBA-175 with respect to the microneme protein 
EBA-181, the two fluorescence photomicrographs 
were merged. The function of the mutant 
EBA-175 was measured in each parasite line 
as shown in Fig. 4 A.   refers to absence of 
a switch in invasion demonstrating EBA-175 
function is retained, whereas   signifies a 
switch in invasion phenotype and loss of 
function for EBA-175.T
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The cytoplasmic domain of EBA-175 is required for 
function in merozoite invasion
W2mef invades neuraminidase-treated erythrocytes very in-
efficiently because it is reliant on sialic acid–dependent inva-
sion (Dolan et al., 1990), and EBA-175 is an important
ligand in this process (Duraisingh et al., 2003). Addition-
ally, the loss of function of EBA-175 can be directly mea-
sured in W2mef by a decrease in invasion of chymotrypsin-
treated erythrocytes due to the inability of these parasite
lines to use the chymotrypsin-resistant erythrocyte receptor
glycophorin A (Duraisingh et al., 2003).
The parasite 3D7 can invade via sialic acid–independent
receptors on the erythrocyte, and disruption of the EBA-175
gene does not cause a major shift in use of different receptors
as has been described for W2mef, suggesting that it is not re-
quired for a dominant invasion pathway in this particular
parasite line. However, EBA-175 is functional, and this has
been demonstrated by a significant decrease in the ability of
 EBA-175 3D7 parasites to invade chymotrypsin-treated
erythrocytes (Duraisingh et al., 2003).
These parameters provided a measure of EBA-175 func-
tion in merozoite invasion and allowed us to test the func-
tionality of mutant EBA-175 ligands in transgenic parasites.
To determine the effect of the different mutations in the
EBA-175 cytoplasmic domain on the function of this pro-
tein in merozoite invasion, we first tested the ability of the
transgenic parasites to invade neuraminidase-treated eryth-
rocytes (Reed et al., 2000a; Duraisingh et al., 2003). The
loss of EBA-175 function in transgenic parasites that re-
sulted in an increased invasion of neuraminidase-treated
erythrocytes was confirmed by testing their ability to invade
chymotrypsin-treated cells.
W2mefY1419, W2mefY1464, W2mefYY, W2mefEDD,
W2mef 15, and W2mefY 15 invaded neuraminidase-
treated erythrocytes as inefficiently as parental W2mef and
the transfection control W2mef3 R, suggesting that EBA-
175 was fully functional (Fig. 4 A). This suggested that
these specific amino acid residues are not required for the
function of EBA-175 in P. falciparum. This was in con-
trast to the loss of function of EBA-175 as a result of de-
letion of 54 amino acids from the cytoplasmic tail.
W2mef tail parasites that express a truncated form of
EBA-175 lacking the cytoplasmic domain invade neu-
raminidase-treated erythrocytes efficiently (77%), whereas
parental parasites W2mef and the transfection control
(W2mef3 R) invade at  16% compared with the invasion
of untreated RBCs (Fig. 4 A). The loss of function of the
truncated EBA-175 proteins was verified by demonstra-
tion that W2mef tail parasites invade chymotrypsin-
treated erythrocytes significantly less than W2mef and
W2mef3 R parasites (Fig. 4 B). This switch in invasion
phenotype was analogous to that seen for the W2mef 230
parasites (Fig. 4, A and B; Reed et al., 2000a; Duraisingh
et al., 2003). The baseline level for reinvasion between
mutant EBA-175 parasites and wild-type parental lines is
higher compared with that described previously (Durai-
singh et al., 2003). This is likely to be a reflection of the al-
tered quantification methods and assay conditions used in
the independent studies; however, importantly, the mag-
nitude of the differences is similar in this paper compared
with previous data (Reed et al., 2000a; Duraisingh et al.,
2003).
To determine the effect of the loss of the EBA-175 cyto-
plasmic tail in parasites such as 3D7, which invade primar-
ily using nonsialic acid processes, we tested the ability of
3D73 R and 3D7 tail to invade neuraminidase- and chy-
motrypsin-treated erythrocytes (Fig. 4, A and B). As
expected, there was no significant difference between
3D73 R, expressing full length EBA-175, and 3D7 tail in
their ability to invade neuraminidase-treated erythrocytes.
This is in agreement with our previous results comparing
3D7 and  EBA-175 3D7 parasites (Duraisingh et al.,
2003). However, 3D7 tail invaded chymotrypsin-treated
erythrocytes significantly less than 3D73 R parasites, con-
sistent with the loss of function of the EBA-175 protein as
a result of truncation of the cytoplasmic tail (Fig. 4 B).
This suggests that the cytoplasmic domain of EBA-175 is
essential for the function of this protein in parasite lines
Figure 4. The deletion of the cytoplasmic domain of EBA-175 
leads to a switch in the invasion phenotype. The TRAP cytoplasmic 
tail can reconstitute the function of the same region in EBA-175 
for merozoite invasion. The ability to invade neuraminidase-treated 
erythrocytes is indicative of a switch in invasion to sialic acid inde-
pendence and loss of EBA-175 function and this loss of function 
was confirmed directly by measurement of the ability to invade 
chymotrypsin-treated erythrocytes. RBCs were treated with neura-
minidase (A) or chymotrypsin (B) as described in Materials and 
methods before testing in merozoite invasion assays. Figures shown 
are the percentage of invasion compared with untreated erythrocytes. 
Error bars correspond to standard deviation. The data obtained with 
neuraminidase-treated erythrocytes were from four independent 
experiments for W2mef, W2mef3 R and W2mef tail but only two 
independent experiments for W2mefTRAP. All experiments were 
performed in triplicate. The data obtained in panel B with chymo-
trypsin-treated erythrocytes represent one experiment done in 
triplicate. A second independent experiment has been performed 
and the results obtained are essentially the same as described here.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
Function of EBA-175 in P. falciparum | Gilberger et al. 323
that invade via sialic acid–independent or –dependent
pathways. Importantly, the loss of function in W2mef tail
and 3D7 tail parasites was not the result of incorrect traf-
ficking or lower expression, but rather the inability of the
truncated protein to participate in the invasion process.
The cytoplasmic domain of EBA-175 can be substituted 
by TRAP
EBA-175 functions in merozoite invasion of erythrocytes
(Sim et al., 1994; Reed et al., 2000a), whereas TRAP is re-
quired for invasion of sporozoites into liver cells (Sultan et al.,
1997). To test if the cytoplasmic tail of the TRAP protein
was able to substitute for the same region in EBA-175, we re-
placed the COOH-terminal 54 amino acids with the last 37
amino acids of TRAP (Fig. 1 B). As expected, no fluorescence
was detectable with anti-TRAP antibodies in W2mef. How-
ever, anti-TRAP-CT detected the EBA-175TRAP chimeric
protein in W2mefTRAP parasites, and this protein showed
colocalization with the micronemal marker EBA-181 in schiz-
onts and merozoites (Fig. 3 and Fig. 5).
To test the functionality of the chimeric EBA-175TRAP
protein in the transgenic cell line, we tested their ability to
invade neuraminidase- and chymotrypsin-treated erythro-
cytes. Importantly, W2mefTRAP parasites invade neu-
raminidase- and chymotrypsin-treated erythrocytes at ap-
proximately the same efficiency as W2mef and W2mef3 R,
conclusively demonstrating that the EBA-175TRAP chi-
mera is fully functional (Fig. 4, A and B). Therefore, the cy-
toplasmic tail of TRAP can be substituted for the same do-
main from EBA-175 in merozoite invasion.
Discussion
The life cycle of Plasmodia is complex, requiring invasion of
different cell types in the host and the mosquito vector. Rec-
ognition of the cell by the sporozoite and merozoite during
the invasion process occurs by binding of specific ligands ex-
pressed in each life cycle stage to their cognate receptor on
the target cell. The TRAP protein is essential for gliding mo-
tility and invasion of sporozoites into liver cells (Sultan et al.,
1997; Kappe et al., 1999), whereas EBA-175 functions in
merozoite invasion of erythrocytes using glycophorin A as
receptor (Sim et al., 1994). The cytoplasmic tail of TRAP
and EBA-175 show no obvious homology except a degener-
ate tyrosine-based motif and a high content of acidic amino
acids (Di Cristina et al., 2000). It has been suggested that
this region plays an important role in trafficking of the pro-
teins to the micronemes, and interaction with the microfila-
ment system via an actin–myosin motor to drive entry of the
parasite into the host cell during the invasion process (Kappe
et al., 1999; Bergman et al., 2003). Here, we have shown
that the cytoplasmic tail of EBA-175 is required for the role
of this protein in merozoite invasion and that the same re-
gion of the sporozoite TRAP protein is functionally equiva-
lent. The functional homology of the EBA-175 cytoplasmic
tail with that of TRAP suggests that the protein–protein in-
teractions involved in linking these proteins to the sporozo-
ite and merozoite molecular machinery for invasion into
such different host cells as hepatocytes and erythrocytes are
the same for the parasite life cycle stages.
Specificity of host cell target for sporozoites and merozo-
ites presumably resides in the specific ligand(s) expressed in
each life cycle stage. For example, merozoites express the
ligands EBA-175 and EBA-140, and these bind glyco-
phorin A (Sim et al., 1994) and C (Maier et al., 2003;
Mayer et al., 2001; Thompson et al., 2001). In contrast, the
TRAP protein in sporozoites binds to receptors on hepato-
cytes, probably via heparin sulfate or certain sulfated glyco-
conjugates (Holt et al., 1990; Cerami et al., 1992). After
initial receptor binding of the ligands, they presumably par-
ticipate in movement of the tight junction between the host
cell and merozoite or sporozoite by binding of the cytoplas-
mic tail either directly or via an adaptor protein to an actin–
myosin based motor system (Barnwell and Galinski, 1998;
Pinder et al., 1998; Opitz and Soldati, 2002). The ability to
substitute the cytoplasmic tail of TRAP for that of EBA-
175 suggests that both are able to bind to the same adaptor
protein required for merozoite invasion via glycophorin A
on the erythrocyte.
Analysis of TRAP cytoplasmic tail function in the mouse
malaria Plasmodium berghei (PbTRAP) has shown that spe-
cific alterations can block infectivity of hepatic cells and in
addition, drastically modify gliding motility (Kappe et al.,
1999). It has been suggested that the PbTRAP tail is bifunc-
tional, with the proximal part required for protein transloca-
tion along the cortical microfilaments, whereas the distal re-
gion contains the signal for release of TRAP at the posterior
end, probably by proteolytic cleavage. A penultimate tryp-
tophan residue and a group of acidic amino acid residues
present near the COOH terminus of the PbTRAP tail have
been shown to be critical for invasion and normal gliding
movement (Kappe et al., 1999). The tryptophan residue is
Figure 5. Expression and localization of EBA-175TRAP in trans-
genic parasites. Immunofluorescence assays using anti-TRAP-CT, 
anti-EBA-175 and anti-EBA-181 antibodies with parasite lines 
W2mef and W2mefTRAP are shown. Structural features of EBA-175 
compared with the chimeric protein EBA-175TRAP. Nuclei are 
stained with DAPI in the first panel of each row. EBA-175 colocalizes 
with the microneme protein EBA-181 in W2mef parasites. 
EBA-175TRAP is not expressed in W2mef parasites but is expressed 
in W2mefTRAP transgenic parasites. It colocalizes with the micro-
nemal protein EBA-181. The EBA-175 and EBA-181 patterns are 
merged to show colocalization in the last panel of each row.T
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conserved in a number of putative TRAP paralogues and
orthologues that function in sporozoites and tachyzoites
from Apicomplexan parasites; however, it is not present in
EBA-175 or any of its paralogues known to be involved in
merozoite invasion of erythrocytes (Fig. 1 A). Additionally,
the acidic residues at the COOH terminus of EBA-175 are
not required for normal function in merozoite invasion, and
these results suggest differences in the role of the EBA-175
cytoplasmic tail compared with that suggested for TRAP.
The EBA-175 tail may be involved in protein translocation
along the cortical microfilaments, probably via an adaptor
protein similar to that envisaged for TRAP, but it is likely
that release at the posterior pole of the sporozoite or merozo-
ite for the two proteins may involve different processes (Sul-
tan et al., 1997; Kappe et al., 1999). It would be interesting
to test the interchangeability of the cytoplasmic domains for
sporozoite invasion by generating a parasite line with a chi-
meric TRAP/EBA175 protein, either with or without an ad-
ditional penultimate tryptophan.
The ability to substitute the EBA-175 cytoplasmic tail
with the equivalent region of TRAP would imply amino
acid conservation. However, there is no obvious homology
in this region between EBA-175 and TRAP, suggesting
that the functional determinants are dependent on the ter-
tiary structure of the cytoplasmic domains. This is consis-
tent with the lack of amino acid homology between the
EBA-175 cytoplasmic tail and its paralogues, such as
EBA140 and EBA-181 (Fig. 1 A; Gilberger et al., 2003;
Maier et al., 2003). The main feature of the cytoplasmic
domain of these proteins is their highly charged nature,
and it is likely that this is a key element in interaction with
a putative adaptor protein and the merozoite invasion ma-
chinery. To further analyze sequence requirements for the
proposed interaction, it would be of great interest to test if
a charged mutant and/or random cytoplasmic domain of
approximately the same size could functionally substitute
the endogenous EBA-175 domain.
The general importance of the cytoplasmic domain is
demonstrated by the deletion of the cytoplasmic domain of
EBA-175 in either W2mef or 3D7 (W2mef tail and
3D7 tail) parasites that express functionally inactive forms
of this ligand. The reported phenotype of these parasite lines
was not due to lower expression of the mutant protein, as
previously described for certain circumsporozoite protein
mutants in P. berghei (Thathy et al., 2002), nor was it a re-
sult of incorrect trafficking as the protein was localized to the
micronemes (Di Cristina et al., 2000). The EBA-175 tail
mutants show a complete loss of EBA-175 function in both
sialic acid–dependent and –independent parasites.
The importance of specific amino acid motifs in the cy-
toplasmic tail of type 1 transmembrane proteins for post-
secretory targeting to their subcellular location has been in-
tensively studied in higher eukaryotes. These proteins enter
the secretory pathway with their NH2-terminal signal se-
quence that cotranslationally direct the proteins into the
ER. Type 1 transmembrane proteins can have tyrosine-
based motifs in their cytoplasmic tail required for post-
Golgi sorting by binding to adaptor protein complexes
that are involved in vesicular transport (Bonifacino and
Dell’Angelica, 1999). In contrast to this detailed knowl-
edge, very little is known about the molecular mechanisms
of protein trafficking in Apicomplexa. It has been shown in
T. gondii that tyrosine-based motifs and an acidic amino
acid motif are also required for sorting and trafficking of
type 1 membrane proteins to the micronemes and rhop-
tries (Di Cristina et al., 2000; Hoppe et al., 2000; Reiss et
al., 2001). This is in contrast to EBA-175 in P. falciparum,
a protein that does not require tyrosine-based motifs or in-
deed the cytoplasmic tail for correct sorting to the micron-
emes, although this region is essential for the function of
this protein in invasion.
The rhoptry protein RAP1 acts as an escorter for RAP2 in
P. falciparum, suggesting that complex formation may be
important in sorting and subcellular targeting in Apicom-
plexan parasites (Baldi et al., 2000). Similarly, in T. gondii,
the type 1 transmembrane protein MIC6 and MIC8 act as
escorters for the soluble proteins MIC1, MIC4, and MIC3
for trafficking to the micronemes, and these complexes ap-
pear to play an important role in the invasion of tachyzoites
into mammalian cells (Reiss et al., 2001). The cytoplasmic
domains of MIC6 and MIC8 appear to contain the infor-
mation required for correct microneme localization of the
complexes, as has been shown for MIC2 (Di Cristina et al.,
2000). Deletion of the transmembrane and cytoplasmic do-
main of MIC8 led to incorrect localization of the protein
(Cerede et al., 2002), and this is similar to the results ob-
served with deletion of the 3  cysteine-rich region, trans-
membrane, and cytoplasmic domain of EBA-175 (Fig. 3).
However, it was unexpected that the cytoplasmic domain of
EBA-175 was not required for protein sorting to the mi-
cronemes. Correct sorting of truncated EBA-175 lacking
the cytoplasmic tail to the micronemes suggests another
protein with the necessary localization signals may be in-
volved in directing this protein and its paralogues to their
subcellular localization.
The results presented here suggest a model for trafficking
of EBA-175 that involves an escorter protein specifying the
targeting information required for microneme localization
(Fig. 6, A and B). We presume that EBA-175 and other mi-
croneme proteins are processed through the classical secre-
tory pathway involving the ER and Golgi followed by un-
known sorting machinery in the TGN (Fig. 6 A). The
trafficking of EBA-175 to the micronemes is independent of
the cytoplasmic domain, and we propose that an escorter
protein forming a complex is required for this specific sort-
ing event (Fig. 6 B). The inability of EBA-175 230 protein
to be trafficked to the micronemes suggests that the cysteine-
rich region and/or the transmembrane domain are involved
in complex formation. It is likely that the 3  cysteine-rich re-
gion is important in protein sorting, as it is conserved in
other paralogues that function in merozoite invasion, and it
is likely that these proteins are sorted and localized to the
micronemes by identical mechanisms.
Furthermore, functional EBA-175 requires linkage of the
cytoplasmic domain to the invasion machinery either di-
rectly or via an adaptor protein (Fig. 6 C). This interaction
can be substituted by the cytoplasmic tail of TRAP, sug-
gesting that this family of proteins have the information re-
quired for function in the invasion process encrypted in
their cytoplasmic tail. An increased understanding of theT
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role of the cytoplasmic tail of these proteins in invasion will
help identify potential new drug targets that block the in-
fectivity of this parasite at the liver and erythrocyte stage of
the life cycle.
Materials and methods
Parasite strains and transfection
P. falciparum asexual stages were cultured in human 0
  erythrocytes ac-
cording to standard procedures (Trager and Jensen, 1976). Human 0
  were
provided by the Blood Bank, Melbourne (Melbourne, Australia). W2mef is
derived from the Indochina III/CDC strain. W2mef and 3D7 parasites were
transfected as described previously (Crabb and Cowman, 1996; Wu et al.,
1996) with 80  g purified plasmid DNA (QIAGEN). Positive selection for
transfectants was achieved using 10 nM WR99210, an antifolate that se-
lects for the presence of the human dhfr gene (Fidock and Wellems, 1997).
Nucleic acid and sequence analysis
Chromosome 7 of P. falciparum was sequenced by the Sanger Center (http://
www.sanger.ac.uk; Gardner et al., 2002). Preparation of genomic DNA was
performed as described previously (Triglia et al., 1998). DNA sequencing was
performed using BigDye
® Terminator Cycle sequencing (PerkinElmer). South-
ern blotting was performed using standard procedures. In vitro mutagenesis of
the 3  region of EBA-175 was achieved using cDNA in either a one- or two-
step primer-directed PCR mutagenesis method with proof reading Vent poly-
merase (Stratagene). An  1-kb fragment of the 3  end of the EBA-175 gene
was amplified with the following primers and sequenced in order to detect
unwanted mutations: 175-S, 5 -TGAGGATCCAGGAAATGATACATCT-
GAAATGTCGCA-3 ; 175 3 R-AS, 5 -AGTCTCGAGTCATATCTTAAATT-
TAATATCATT-3 ; 175Y1464-AS, 5 -GCGCCTCGAGTCATATCTTAAATTT-
AATATCATTTATATCCTCATGCCTTCAG-3 ; 175EDD1470-AS, 5 -AGTCT-
CGAGTCATATCTTAAATTTAATACCATTTATACCCCCATGGTA-3 ; 175 15-
AS, 5 -GCGCCTCGAGTCAATCGTTGATATTAGTTT-3 ; 175 tail-AS, 5 -
AGCCTCGAGTCAACTTTGATATTTGGCTTGTGA-3 ; 175Y1419-AS, 5 -
CTTTGACCTTTGGCTTGTGAAGC-3 ; 175Y1419-S, 5 -GCTTCACAAGCC-
AAAGGTCAAAG-3 ; 175TRAP-AS, 5 -GGCAAAGGGTGTTGCACTTTG-
ATATTTGGCTTGTGAAGC-3 ; TRAP-S, 5 -GCAACACCCTTTGCCGGA-3 ;
TRAP-AS, 5 -AGTCTCGAGTTAATTCCACTCGTTTTCTTC-3 . The bases in
italics refer to restriction enzyme sites used for cloning.
All PCR products were subcloned into BamHI/XhoI pBluescript
®, ampli-
fied, and digested with BamHI and XhoI. Using the compatibility of the 5 
overhangs of BglII and BamHI, the fragments were subsequently cloned
into a BglII/XhoI precut pHH1 transfection vector (Reed et al., 2000b).
To construct pHH1-YY and pHH1Y 15, the pBluescript
® construct
pBSEBA175Y1419 was used as a template for PCR mutagenesis.
Antisera and immunoblots
Rabbit and mouse antisera were raised against the cytoplasmic domain of
EBA175 and PfTRAP using the pGEX system (Amersham Biosciences).
Other antibodies used in immunodetection were rabbit anti-EBA175 (Reed
et al., 2000b) and anti-HSP70 antibodies. For immunoblots, parasite pro-
teins from a synchronized culture were separated on 6% SDS-PAGE gels
and transferred to nitrocellulose membranes (Schleicher & Schuell).
EBA175-CT, TRAP-CT, and EBA-175 rabbit antisera were diluted 1:250,
and HSP70 antisera was diluted 1:5,000 in PBS with 1% wt/vol skim milk.
The secondary antibody was sheep anti–rabbit IgG HRP (Silenus Laborato-
ries). The immunoblots were developed by chemiluminescence using ECL
(Amersham Biosciences).
Real-time RT-PCR
Synchronized parasites were harvested in the late schizont stage and total
RNA was isolated using TRIzol
® (Invitrogen). RNA was further purified by
DNase digestion on an RNeasy
® column (QIAGEN). 2  g of total RNA
were reverse transcribed either with or without SuperScript™ II using An-
chor T and random nonamers (Invitrogen). The LightCycler
® (Roche) was
used to quantitate cDNA using QuantiTect SYBR
® Green PCR Kit
(QIAGEN) and gene specific primers. Reaction conditions were 94 C for
15 min, 45 C for 20 min, and 65 C for 30 min. EBA175F, 5 -AATTTCTG-
TAAAATATTGTGACCATAT-3 ; EBA175R, 5 -GATACTGCACAACACA-
GATTTCTT-3 ; ACTINF, 5 -TGCACCACCAGAGAGAAAAT-3 ; ACTINR,
5 -ACTTGGTCCTGATTCATCGT-3 ; H2BF, 5 -TGGTCCAGATGGAAA-
GAAAA-3 ; and H2BR, 5 -TCGAAAGTATCAACAAGGAATG-3 .
Serial dilutions of 3D7 genomic DNA were used as a standard reference
control. The relative expression ratios of EBA175 compared with the two
reference genes, actin and histone 2B, were calculated for each strain after
subtracting the signal generated by samples with no reverse transcriptase.
Immunofluorescence
Immunofluorescence assays were performed with synchronized parasites.
Late schizonts were smeared, air dried, and fixed for 1 min with 100%
methanol at  20 C. Slides were incubated for 1 h with a mixture of rabbit
anti-EBA175 (1:1,000) or anti-TRAP-CT (1:1,000) and mouse anti-EBA181
(1:1,250), washed three times for 10 min with 0.05% Tween 20-PBS, and
then incubated for 1 h with fluorescein isothiocyanate–labeled sheep anti–
mouse IgG antibodies (Silenus Laboratories), rhodamine-labeled goat anti–
rabbit IgG antibodies (CHEMICON International) and DAPI (1:1,250;
Figure 6. A proposed model of traffick-
ing and function for EBA-175. (A) Sche-
matic representation of a merozoite. 
Secretory proteins enter the lumen of the 
endoplasmic reticulum (ER) with their 
NH2-terminal signal peptide. The molec-
ular mechanism of pre- and post-Golgi 
trafficking (TGN) and the differential 
sorting of microneme (MIC) and rhoptry 
(R) proteins to their final destination 
is unclear. (B) In a post-Golgi sorting 
event, EBA-175 is trafficked to the 
micronemes by an escorter protein. 
The protein–protein interaction may take 
place via the conserved 3  cysteine-rich 
region. The information of neither 
microneme localization nor interaction 
with the escorter protein is encrypted 
in the cytoplasmic domain of EBA-175. 
Deletion of the cytoplasmic domain 
does not affect sorting to the micronemes. 
Sorting was disrupted by deletion of the 
transmembrane domain and the 3  cys-
teine rich region. (C) The intracellular 
function of EBA-175 is dependent on the 
interaction of an adaptor protein with the cytoplasmic domain. The deletion of this region abolishes the binding of the adaptor protein and 
leads to disruption of its function. The cytoplasmic domain can be substituted by the cytoplasmic domain of the sporozoite protein TRAP, 
suggesting that EBA-175 and TRAP have functionally equivalent roles in the active invasion process.T
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Boehringer). Dual-color fluorescence images were captured using a micro-
scope (Axioskop 2; Carl Zeiss MicroImaging, Inc.) and a digital camera
(PCO sensicam).
Erythrocyte enzyme treatments and invasion assay
Parasite erythrocyte invasion assays were performed to characterize the in-
vasion phenotype of the W2mef-EBA175 transgenic lines (Reed et al.,
2000a). Surface modification of the erythrocytes was achieved by similar
treatment as described elsewhere (Dolan et al., 1994): 500  l 1  g/ml chy-
motrypsin of packed erythrocytes were incubated with either 50 mU
neuraminidase or 1.5 mg/ml trypsin. Tightly synchronized parasite cultures
were treated with neuraminidase and trypsin to prevent reinvasion. Ring
stage cultures were adjusted to 2% parasitemia and treated with
neuraminidase for 1 h at 37 C (50 mU for 200  l packed, infected erythro-
cytes in 1 ml RPMI 1640/Hepes/0.2% NaHCO3). After washing twice with
RPMI 1640/Hepes/0.2%NaHCO3, the infected cells were incubated with
trypsin (1 mg/ml in RPMI 1640/Hepes/0.2% NaHCO3) for 1 h at 37 C fol-
lowed by incubation with trypsin inhibitor (1 mg/ml in RPMI 1640/Hepes/
0.2% NaHCO3; Sigma-Aldrich) for 10 min at RT. The cultures were
washed, resuspended in complete medium, and incubated overnight un-
der standard conditions. The invasion assays were set up the next day by
mixing equal amounts of infected double-enzyme treated cells (schizont
stage) with uninfected normal or enzyme-modified erythrocytes to a final
hematocrit of 3%. 100- l aliquots of each culture in triplicate were put
into a 96-well microtiter plate. The parasitemia in each well was counted
by FACScan™ using Retic-COUNT™ (Becton Dickinson). After 36 h of in-
cubation, the parasitemia of each well was counted again by FACScan™.
Parasitemias were confirmed by microscopic counting of Giemsa-stained
thin blood smears and subsequently compared with the starting para-
sitemia. Control wells with unstained culture and stained uninfected eryth-
rocytes were included in FACScan™ and in the microscopic counting to
enable background correction.
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